BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2011
View Archived Issues
Almac Discovery reports preclinical antiangiogenic activity for ALM-201
Read More
IND application filed for mTOR/PI3K-alpha inhibitor PWT-33597 based on in vivo antitumor action
Read More
Preclinical data provide support for GDC-0980 in phase I trials
Read More
Suven Life Sciences' histamine H3 receptor antagonist improves cognitive performance in vivo
Read More
Snapshots: New data on boceprevir in hepatitis C presented at EASL meeting
Read More
Janssen Pharma's new analgesics JNJ-40413269 and JNJ-40534832 show promise in vivo
Read More
Novel beta-lactamase inhibitors patented by Nabriva
Read More
GE Healthcare and Hammersmith Imanet present novel radiolabeled gallium complexes
Read More
Primary efficacy objective met in phase III GetGoal-S trial of lixisenatide in type 2 diabetes
Read More
First patient enrolled in phase II study of Zybrestat/bevacizumab in ovarian cancer
Read More
New inhibitors claimed of interaction between integrin alpha-4 and paxillin
Read More
New modulators of nicotinic acetylcholine alpha7 receptor claimed
Read More
NeuroSearch patents new monoamine uptake inhibitors for mood disorders
Read More
Novel modulator presented of metabotropic glutamate mGlu5 receptor
Read More
New modulators of voltage-gated calcium channels designed at Zalicus
Read More
Eteplirsen is approved as USAN name for AVI-4658
Read More
FDA committee votes in favor of Pfizer's Sutent in unresectable pancreatic NET
Read More
First patient treated in phase I TOPAS study of 4SC's selective HD inhibitor 4SC-202
Read More
Pieris and Daiichi Sankyo to collaborate on development of novel Anticalin therapeutics
Read More
Kyowa Hakko Kirin launches Romiplate in Japan for chronic ITP
Read More
Xiapex launched in E.U. for Dupuytren's contracture
Read More
FDA advisory committee recommends approval of Novartis' Afinitor for advanced pancreatic NET
Read More
Taiho and Helsinn sign agreement for netupitant/palonosetron fixed-dose combination in Japan
Read More
Immunovaccine reports interim phase I data on anticancer vaccine DPX-0907
Read More
PharmaMar begins phase II Yondelis trial in advanced breast cancer
Read More
Morphotek receives additional DOD funding to develop therapeutic mAbs against biowarfare agents
Read More